Command Palette

Search for a command to run...

Clinical Trials · NCT05360537

Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Palermo
Enrollment
100
Start date
Apr 2021
Locations
1 site, Italy
Primary endpoint
Change of Time in Range % at 7 days, at 1 and 6 months
View Liraglutide compound reference